awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534997-52A987D9-0B02-41EA-967D-064607F0F607
Q28534997-52A987D9-0B02-41EA-967D-064607F0F607
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534997-52A987D9-0B02-41EA-967D-064607F0F607
Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer
P2860
Q28534997-52A987D9-0B02-41EA-967D-064607F0F607
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534997-52A987D9-0B02-41EA-967D-064607F0F607
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d92d169062a3f426a836d58d4cb28877be1d64b
P2860
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.